Anand B Karnad

Fingerprint Dive into the research topics where Anand B Karnad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

Neoplasms Medicine & Life Sciences

Breast Neoplasms Medicine & Life Sciences

Acquired Immunodeficiency Syndrome Medicine & Life Sciences

Drug Therapy Medicine & Life Sciences

House Calls Medicine & Life Sciences

Plasmacytoma Medicine & Life Sciences

Medical Oncology Medicine & Life Sciences

Multiple Myeloma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1991 2019

1 Finished

INSTITUTE FOR CANCER RESEARCH AND CARE

Hinck, A. P., Sarantopoulos, J., Curiel, T. J., Lafer, E. M., Weintraub, S. E., Karnad, A. B., Lechleiter, J. D., Thompson, I. M., Leach, R. J., Christy, B. A., Allred, C., Johnson, K., Padmanabhan, S., I-Tien, Y., Naylor, S., Gazitt, Y., Pollock, B. H., Mundy, G., Bonewald, L., Davis, S., Lee, E., Oishi, N., Hasty, E., Vijg, J. N. M. N., Herman, B. A., Johnson, K., Moyer, M., Windle, J., McGill, J., O'Connell, P., Clark, G., Kuhn, J., Wolf, R., Allred, D. C., Weiss, G., Boldt, D., Coltman, C. & Huang, H.

National Institutes of Health

9/1/91 → 7/31/19

Project: Research project

Neoplasms

Research

Health

Hispanic Americans

Financial Management

Research Output 1984 2018

1179 Citations
20 h-Index
72 Article
2 Letter
1 Review article

4 Citations (Scopus)

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Kelly, K. R., Friedberg, J. W., Park, S. I., McDonagh, K., Hayslip, J., Persky, D., Ruan, J., Puvvada, S., Rosen, P., Iyer, S. P., Stefanovic, A., Bernstein, S. H., Weitman, S. D., Karnad, A. B., Monohan, G., VanderWalde, A., Mena, R., Schmelz, M., Spier, C., Groshen, S. & 5 others, Venkatakrishnan, K., Zhou, X., Sheldon-Waniga, E., Jane Leonard, E. & Mahadevan, D., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6150-6159 10 p.

Research output: Contribution to journal › Article

Aurora Kinase A

Vincristine

B-Cell Lymphoma

Non-Hodgkin's Lymphoma

Lymphoma, Large B-Cell, Diffuse

63 Citations (Scopus)

The biology and role of CD44 in cancer progression: Therapeutic implications

Chen, C., Zhao, S., Karnad, A. B. & Freeman, J. W., May 10 2018, In : Journal of Hematology and Oncology. 11, 1, 64.

Research output: Contribution to journal › Review article

Neoplasms

Epithelial-Mesenchymal Transition

Neoplastic Stem Cells

Hyaluronic Acid

Therapeutics

20 Citations (Scopus)

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): A randomised, phase 3 study

Herbst, R. S., Redman, M. W., Kim, E. S., Semrad, T. J., Bazhenova, L., Masters, G., Oettel, K., Guaglianone, P., Reynolds, C., Karnad, A. B., Arnold, S. M., Varella-Garcia, M., Moon, J., Mack, P. C., Blanke, C. D., Hirsch, F. R., Kelly, K. & Gandara, D. R., Jan 1 2017, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journal › Article

Carboplatin

Paclitaxel

Non-Small Cell Lung Carcinoma

Fluorescence In Situ Hybridization

Control Groups

2 Citations (Scopus)

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

Fountzilas, C., Stuart, S., Hernandez, B., Bowhay-Carnes, E., Michalek, J. E., Sarantopoulos, J., Karnad, A. B., Patel, S., Weitman, S. D. & Mahalingam, D., Jan 19 2017, (Accepted/In press) In : Investigational New Drugs. p. 1-6 6 p.

Research output: Contribution to journal › Article

Liver Diseases

Serum Albumin

Liver

Survival

Survival Analysis

14 Citations (Scopus)

Safety and pharmacodynamics of the PDE4 inhibitor roflumilast in advanced B-cell malignancies

Kelly, K., Mejia, A., Suhasini, A. N., Lin, A. P., Kuhn, J., Karnad, A. B., Weitman, S. D. & Aguiar, R. C., Mar 1 2017, In : Clinical Cancer Research. 23, 5, p. 1186-1192 7 p.

Research output: Contribution to journal › Article

Phosphodiesterase 4 Inhibitors

B-Lymphocytes

Phosphatidylinositol 3-Kinases

Safety

Neoplasms